EN
HI
Summary
As of 1 Sep, 2026, Vista Pharmaceuticals stock price is ₹6.4. During the trading session, the stock has moved between an intraday low of ₹5.80 and an intraday high of ₹6.41. Over the last 52 weeks, Vista Pharmaceuticals has traded between ₹5.71 and ₹10.75.
The stock has recorded a trading volume of 9,143 shares, with a market capitalization of ₹58195365. Its Average Traded Price (ATP) is ₹6.03, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 33 @ ₹6.40.
Vista Pharmaceuticals has an upper circuit limit of ₹7.60 and a lower circuit limit of ₹5.08. The total value traded stands at ₹55132.29, and the delivery percentage for the day is 99.88%.
The stock is currently traded with a market lot size of 1. Vista Pharmaceuticals also offers a dividend yield of 0%.
Vista Pharmaceuticals share price chart
Vista Pharmaceuticals Share Key Metrics
Volume
9143.00
Market Cap
36.49 CR
LTQ@LTP
33@6.40
ATP
6.03
Var Margin
30.78 %
Circuit Range
5.08-7.6
Delivery %
99.88 %
Value
55132.29
ASM/GSM
No
Market Lot
1
Vista Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Vista Pharmaceuticals Resistance and Support
Pivot 6.29
Resistance
First Resistance
6.53
Second Resistance
6.73
Third Resistance
6.97
Support
First Support
6.09
Second Support
5.85
Third Support
5.65
Vista Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 6.41 | 6.4 | 0.95% | 6.41 | 5.8 |
| Fri Aug 28 2026 | 6.17 | 6.34 | 5.49% | 6.48 | 6.05 |
| Thu Aug 27 2026 | 6.15 | 6.01 | -0.33% | 6.32 | 6 |
Vista Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-19 | Preferential Issue of shares & Others |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Vista Pharmaceuticals News
Vista Pharmaceuticals Ltd - 524711 - Board Meeting Outcome for Results For The Quarter Ended 30.06.2026
Vista Pharmaceuticals reported a Q1 FY27 net loss of ₹98.59 lakhs, with revenue sharply down to ₹3.99 lakhs. Credit facilities have been classified as NPA due to debt servicing defaults, significantly impacting operational liquidity and raising going concern issues. The company also secured a ₹9.22 crore undertaking for warrant call money.
Aug 14 2026 15:36:11
Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for Approval Of Un Audited Financials Results For The Quarter Ended 30.06.2026
Vista Pharmaceuticals' Board will meet on August 14, 2026, to consider and approve the financial results for Q1 FY27. The agenda also includes the limited review report for the same period.
Aug 13 2026 10:41:10
Vista Pharmaceuticals Management
| Name | Position |
|---|---|
| Dhananjaya Alli | Chairman |
| Murali Meraga | Managing Director |
Vista Pharmaceuticals FAQs
The Buying Price of Vista Pharmaceuticals share is 6.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Vista Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vista Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Vista Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Vista Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Vista Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Vista Pharmaceuticals is 36.49 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Vista Pharmaceuticals share price is 10.75 & 5.71. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Vista Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
